UBS recommends tech, financials, industrials and utilities stocks going into 2025, citing continued AI growth and ...

UBS started coverage on U.S. government IT and services companies, highlighting a mix of growth potential and risks amid ...

UBS also cut its target price on the firm from AU$3.30 to AU$2.30, and this marks the Swiss bank's first ever downgrade of ...

Capital requirements set for UBS under new banking regulations should be "proportionate", as Switzerland attempts to strike a ...

Dana Incorporated (NYSE: DAN) announced today it will participate in the UBS Global Industrials and Transportation Conference ...

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 18.08% ...

UBS initiated coverage of Leidos (LDOS) with a Neutral rating and $182 price target as the firm initiates coverage on on Government IT & ...

The company amended its compensation plan for next year by trimming payouts for lower-producing financial advisors.

UBS analyst Colin Bristow downgraded Applied Therapeutics (APLT) to Neutral from Buy with a price target of $2, down from $13.Don't Miss our ...

The move risks advisor departures in the short term but could help the Swiss bank improve the profitability of its U.S.

One of UBS's joint venture partners in China will sell its entire holding in a securities company, paving the way for the ...

Gannett Co., Inc. (“Gannett”, “we”, “our”, or the “Company”) (NYSE: GCI) today announced that its Chairman and Chief ...